EP Patent

EP3119749A1 — Antifungal compound process

Assigned to Mycovia Pharmaceuticals Inc · Expires 2017-01-25 · 9y expired

What this patent protects

The present invention relates to a process for preparing compound 1 that is useful as an antifungal agent. In particular, the invention seeks to provide new methodology for preparing compound 1 or la and substituted derivatives thereof.

USPTO Abstract

The present invention relates to a process for preparing compound 1 that is useful as an antifungal agent. In particular, the invention seeks to provide new methodology for preparing compound 1 or la and substituted derivatives thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP3119749A1
Jurisdiction
EP
Classification
—
Expires
2017-01-25
Drug substance claim
No
Drug product claim
No
Assignee
Mycovia Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.